Nathan Sackett, MD, MS is trained as an addiction psychiatrist, focusing on the intersection between substance use and psychiatric disorders. He attended medical school and nursing school at UCSF, graduate school at UC Berkeley and completed his adult psychiatry residency and addiction psychiatry fellowship at the University of Washington. He is now a junior faculty at the University of Washington in the Department of Psychiatry and Behavioral Sciences where he splits his time between seeing patients and research. Clinically, he works primarily outpatient seeing a range of patients with primary psychiatric issues and substance use disorders. His research focuses on the use of psychedelics to treat substance use disorders with a particular interest in how psychedelics can augment the psychotherapeutic process and facilitate behavioral change. When he is not working, he is spending time with his family and playing in the ocean.
I am a clinical psychologist with board certification in geriatric psychology. I am based in the Geriatrics and Extended Care Service of the VA Puget Sound Healthcare System.
Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
In two decades at UW, Dr. Hartzler’s principal focus has been on the dissemination and implementation of empirically-supported health services for persons with substance use disorders. To date, this includes local, regional, national, and international collaborations, encompassing federally-funded work with diverse community-based settings (i.e., addiction care, mental health, primary and specialty medical care, criminal justice, HIV care, schools, faith-based organizations), including those affiliated with the NIDA Clinical Trials Network. As director of the UW Center for Advancing Addiction Health Services (CAAHS), he oversees a broad portfolio, including: 1) the SAMHSA-funded Northwest Addiction Technology Transfer Center (Northwest ATTC), which provides universal, targeted, and intensive technical assistance to the addiction workforce in Alaska, Idaho, Oregon, and Washington 2) regional contribution to SAMHSA’s national Opioid Response Network (ORN), 3) a host of externally-sponsored implementation projects with single-state authorities as well as other organizations, and 4) contribution to NIH-funded and intramural health services research. In professional endeavors that span a science-to-service continuum, Dr. Hartzler seeks to promote adoption and implementation of useful treatment and recovery practices in community settings where they may benefit persons with substance use disorders.
Dr. Banta-Green studies substance use involving opioids and stimulants and interventions to support recovery and reduce substance-related harms. He is particularly interested in developing interventions that are accessible to all people, including those who are most marginalized, such as those who are unhoused, utilizing services syringe service programs, and/or in the criminal legal system. He provides technical assistance and evaluation services for public health and safety interventions including the website http://stopoverdose.org, and information for the general public and professionals about effective treatments at http://learnabouttreatment.org. As an epidemiologist he develops innovative approaches to measuring the use and impacts of substances as well as service utilization. His health services research involves clinical trials, implementation research, and secondary data analyses. He serves on local, state, and federal workgroups and committees related to epidemiology, policy, and interventions for illicit substance-related problems. He is a member of the U.S. Health and Human Service’s Interdepartmental Substance Use Disorders Coordinating Committee.
I have always been interested in the thoughts and feelings that drive us. This led me to major in Psychological and Brain Sciences at Johns Hopkins University and to later enroll in the psychiatry residency training program at Washington University in St. Louis. Since completing training, I have had an excellent experience working at UW/Harborview’s emergency and inpatient psychiatry services. My teaching interests include the psychiatric interview, documentation, and fundamentals of clinical decision-making. Clinically, I enjoy taking a holistic approach to care, utilizing interventions across behavioral changes, pharmacology, and psychotherapy.
Personal Statement
I am a Professor of Psychiatry and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle, Washington. I am also the clinical director of addictions treatment services at Harborview Medical Center, and work in the psychiatric rehabilitation and recovery services.
I am board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine. A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, I am on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health.
